Roche honored 12 doctoral students and two professors with the company’s Excellence in Chemistry Award for research accomplishments in the field of organic chemistry.
Eli Lilly and Company has signed agreements with Care Capital and NovaQuest Capital to establish BioCritica Inc., a privately-held biotechnology company.
GenKyoTex has raised CHF18 million ($20.4 million), which will be used for the clinical development of the lead compound GKT137831 for the treatment of diabetic nephropathy.
A study by researchers at Children’s Hospital Boston and collaborators has provided new insight into how bone cells produce new bone in response to mechanical stresses, such as exercise.
Scientists from the Scripps Research Institute have synthesized of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain treatments.
A group led by University of Wisconsin-Madison stem cell researcher Su-Chun Zhang has; directed embryonic and induced human stem cells to become astrocytes in the lab dish.
Generic drug developer Par Pharmaceutical Companies Inc. said it will buy privately held Edict Pharmaceuticals for up to $37.6 million in cash. Edict, based in Chennai, India, makes solid, oral dose generic drugs.
The Almac Group has officially opened its North American Headquarters in Souderton, PA. The $120 million, 240,000-square-foot building houses more than 800 employees and has already brought approximately 300 new hires to the greater Philadelphia region.
Seward Limited has further enhanced the application range of its Strainer bags to include sterile processing of tissue samples for primary cell preparation. The bags are Gamma irradiated sterile and available in a range of sizes.
PerkinElmer Inc. announced the launch of its Optima 8x00 series of Inductively Coupled Plasma Optical Emission Spectrometers. The Optima 8x00 ICP-OES platform offers improved performance and reduced operating costs.
Anavex Life Sciences Corp. announced that the Safety Review Committee for ANAVEX 2-73, its lead candidate for Alzheimer’s disease, unanimously approved skipping the 5 mg dose and moving directly to the 10 mg dose step.
Abbott announced it filed premarket approval applications to the U.S. Food and Drug Administration for a new molecular diagnostic test designed to detect abnormal gene rearrangements in non-small-cell lung cancer tumors.
Johnson & Johnson said that its Cilag GmbH unit will expand its business in Russia by buying the over-the-counter brands of J B Chemicals & Pharmaceuticals Ltd. for $260 million in cash.
Drugmaker Eli Lilly and Co. said it will work with some private investors to create a privately held biotechnology company to sell the severe sepsis treatment Xigris and possibly develop other drugs.
The Food and Drug Administration approved Vertex Pharmaceuticals Inc.'s hepatitis C drug Incivek Monday, making it the second new treatment to be approved in the last two weeks.